Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice
Abstract Background Pregnant women are at increased risk of thrombotic adverse events. Plasma derived immune globulin (IG) products, which are used in pregnancy for various indications, may contain procoagulant impurity activated coagulation factor XI (FXIa). Procoagulant IG products have been assoc...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12959-020-00245-8 |